Log in
Enquire now
Ocuphire Pharma

Ocuphire Pharma

Ocuphire Pharma is a small Molecules for Ophthalmic Indications.

OverviewStructured DataIssuesContributors
Is a
Organization
Organization
Company
Company
Board of Directors
‌
Sean Ainsworth
0
‌
Jay Pepose
0
‌
James Manuso
0
‌
Susan Benton
0
‌
Mina Sooch
0
Cam Gallagher
Cam Gallagher
0
CEO
‌
Mina Sooch
0
CIK Number
1,228,627
0
Legal Name
Ocuphire Pharma, Inc.
0
Contact Page URL
ocuphire.com/contact
Country
United States
United States
0
Crunchbase URL
crunchbase.com/organiz...e-pharma
Full Address
37000 Grand River Ave., Suite 120 Farmington Hills, MI 48335, USA
0
Industry
Technology
Technology
Biotechnology
Biotechnology
Biomedical engineering
Biomedical engineering
Engineering
Engineering
Biology
Biology
Investors
Michigan Angel Fund
Michigan Angel Fund
IRS Number
113,516,358
0
Latest Funding Round Date
July 22, 2019
LinkedIn URL
@company/ocuphire-pharma
Location
Farmington Hills, Michigan
Farmington Hills, Michigan
0
NAICS Code
325,412
0
Number of Employees (Ranges)
1 – 10
Patents Assigned (Count)
4
Phone Number
+12486819815
0
Pitchbook URL
pitchbook.com/profiles.../55235-26
Place of Incorporation
Delaware
Delaware
0
Previous Name
REXAHN PHARMACEUTICALS, INC.
0
CORPORATE ROAD SHOW DOT COM INC
0
FERRARO FRANK
0
SIC Code
2,834
0
Exchange
Nasdaq
Nasdaq
Stock Symbol
OCUP
0
Ticker Symbol
OCUP
0
Total Funding Amount (USD)
5,000,000
Twitter URL
@ocuphire
Official Website
ocuphire.com

Find more companies like Ocuphire Pharma

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.